Zhang Z, et al. Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates. PLoS ONE. 2012;7: e49265.

Article  ADS  CAS  Google Scholar 

Weston S, et al. A membrane topology model for human interferon inducible transmembrane protein 1. PLoS ONE. 2014;9: e104341.

Article  ADS  Google Scholar 

Li C, et al. Antiviral role of IFITM proteins in classical swine fever virus Infection. Viruses. 2019;11:126–8.

Article  CAS  Google Scholar 

Lewin AR, et al. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem. 1991;199:417–23.

Article  CAS  Google Scholar 

Siegrist F, et al. The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res. 2011;31:183–97.

Article  CAS  Google Scholar 

John SP, et al. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol. 2013;87:7837–52.

Article  CAS  Google Scholar 

Chan YK, et al. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection. PLoS ONE. 2012;7: e34508.

Article  ADS  CAS  Google Scholar 

Feeley EM, et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 2011;7: e1002337.

Article  CAS  Google Scholar 

Lu J, et al. The IFITM proteins inhibit HIV-1 infection. J Virol. 2011;85:2126–37.

Article  CAS  Google Scholar 

Bozzo CP, et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021;12:4584.

Article  ADS  Google Scholar 

Gomez-Herranz M, et al. IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity. J Biol Chem. 2023;299: 102741.

Article  CAS  Google Scholar 

Liu X, et al. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-beta signaling pathway. Cell Death Dis. 2019;10:517.

Article  Google Scholar 

Xu L, et al. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis. Cancer Lett. 2017;393:76–85.

Article  CAS  Google Scholar 

Hu J, et al. Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer. Oncol Rep. 2014;32:2648–56.

Article  CAS  Google Scholar 

Yu F, et al. IFITM1 promotes the metastasis of human colorectal cancer via CAV-1. Cancer Lett. 2015;368:135–43.

Article  CAS  Google Scholar 

Yang J, et al. Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer. Cancer Sci. 2018;109:3115–28.

Article  CAS  Google Scholar 

Tirosh B, et al. “1-8 interferon inducible gene family”: putative colon carcinoma-associated antigens. Br J Cancer. 2007;97:1655–63.

Article  CAS  Google Scholar 

Daniel-Carmi V, et al. The human 1–8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene. Int J Cancer. 2009;125:2810–9.

Article  CAS  Google Scholar 

Andreu P, et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 2006;66:1949–55.

Article  CAS  Google Scholar 

Yang N, et al. Predicative value of IFITM2 in renal clear cell carcinoma: IFITM2 is associated with lymphatic metastasis and poor clinical outcome. Biochem Biophys Res Commun. 2021;534:157–64.

Article  CAS  Google Scholar 

Cai Y, et al. Interferon-induced transmembrane protein 3 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors. Front Immunol. 2021;12: 704965.

Article  CAS  Google Scholar 

Cui Y, et al. Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation. Biochem Biophys Res Commun. 2018;495:733–9.

Article  CAS  Google Scholar 

Koh YW, et al. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma. Pathol Res Pract. 2019;215: 152444.

Article  CAS  Google Scholar 

Sakamoto S, et al. Interferon-induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer. Int J Mol Sci. 2020;21(14):4934.

Article  CAS  Google Scholar 

Lui AJ, et al. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett. 2017;399:29–43.

Article  CAS  Google Scholar 

Yang M, et al. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. Oncol Rep. 2013;30:171–8.

Article  CAS  Google Scholar 

Hou Y, et al. Interferon-induced transmembrane protein 3 expression upregulation is involved in progression of hepatocellular carcinoma. Biomed Res Int. 2021;2021:5612138.

Article  Google Scholar 

Seyfried NT, et al. Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett. 2008;263:243–52.

Article  CAS  Google Scholar 

Zhao B, et al. The role of IFITM3 in the growth and migration of human glioma cells. BMC Neurol. 2013;13:210.

Article  Google Scholar 

Mizoshiri N, et al. The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma. Cell Oncol (Dordr). 2019;42:861–71.

Article  CAS  Google Scholar 

Liu Y, et al. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Cancer Gene Ther. 2020;27:38–44.

Article  CAS  Google Scholar 

Liang Y, et al. Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming. Mol Cancer. 2022;21:182.

Article  CAS  Google Scholar 

Akyerli CB, et al. Expression of IFITM1 in chronic myeloid leukemia patients. Leuk Res. 2005;29:283–6.

Article  CAS  Google Scholar 

Carmelle R, et al. Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer Biol Ther. 2006;5:1383–9.

Article  Google Scholar 

Wu L, et al. Identification of IFN-induced transmembrane protein 1 with prognostic value in pancreatic cancer using network module-based analysis. Front Oncol. 2021;11: 626883.

Article  CAS  Google Scholar 

Lei Z, et al. Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells. Biosci Biotechnol Biochem. 2020;84:1603–13.

Article  Google Scholar 

Yang G, et al. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene. 2007;26:594–603.

Article  CAS  Google Scholar 

Zhang Y, et al. Increased expression of CD81 is associated with poor prognosis of prostate cancer and increases the progression of prostate cancer cells in vitro. Exp Ther Med. 2020;19:755–61.

ADS  CAS  Google Scholar 

Gan CP, et al. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells. Cell Oncol (Dordr). 2019;42:477–90.

Article  CAS  Google Scholar 

Liu Y, et al. Interferon-induced transmembrane protein 2 promotes epithelial–mesenchymal transition by activating transforming growth factor-beta1/small mother against decapentaplegic 2 signaling in gastric cancer. Mol Biol Rep. 2022;49:997–1006.

Article  CAS  Google Scholar 

Sigismund S, et al. Emerging functions of the EGFR in cancer. Mol Oncol. 2018;12:3–20.

Article  Google Scholar 

Li Q, et al. RUNX1 promotes tumour metastasis by activating the Wnt/beta-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334.

Article  Google Scholar 

Hatano H, et al. IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res. 2008;14:6097–105.

Article  CAS  Google Scholar 

He JD, et al. Influences of the interferon induced transmembrane protein 1 on the proliferation, invasion, and metastasis of the colorectal cancer SW480 cell lines. Chin Med J (Engl). 2012;125:517–22.

CAS  Google Scholar 

Tolomeo M, et al. The multifaced role of STAT3 in cancer and its implication for anticancer therapy. Int J Mol Sci. 2021;22:603.

Article  CAS  Google Scholar 

Weichselbaum RR, et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A. 2008;105:18490–5.

Article  ADS  CAS  Google Scholar 

Khodarev NN, et al. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A. 2004;101:1714–9.